Comparative neuropharmacology of antianxiety drugs

Steven M. Paul, Phil Skolnick

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

Over the past five years, the mechanisms of action of several classes of antianxiety drugs have been clarified. Benzodiazepines, triazolopyridazines, and barbiturates seem to produce their anxiolytic effects by interacting with a specific high affinity receptor (viz. benzodiazepine receptor) in the brain. The benzodiazepine receptor is functionally and perhaps structurally coupled to a receptor for the major inhibitory neurotransmitter GABA as well as a chloride channel or ionophore. Taken together, this receptor "complex" may mediate the behavioral effects of a number of chemically diverse antianxiety agents. Evidence for the role of the benzodiazepine-GABA receptor-chloride ionophore complex in the mechanism of action of minor tranquilizers and a possible interaction with the novel anxiolytic buspirone is discussed.

Original languageEnglish
Pages (from-to)37-41
Number of pages5
JournalPharmacology, Biochemistry and Behavior
Volume17
Issue numberSUPPL. 1
DOIs
StatePublished - 1982

Keywords

  • Antianxiety drugs
  • Buspirone
  • Comparative neuropharmacology

Fingerprint

Dive into the research topics of 'Comparative neuropharmacology of antianxiety drugs'. Together they form a unique fingerprint.

Cite this